Aminocandin

O=C([C@@H](NC([C@](NC([C@@](C[C@H]1O)([H])N(C1)C2=O)=O)([H])[C@H](O)CC(C=C3)=CC=C3O)=O)CO)N(C[C@@H]4C)[C@@](C(NCC(C[C@@H](C(N[C@@]2([H])[C@H](O)C)=O)NC(C5=CC=C(C(C=C6)=CC=C6OCCCCCCCC)C=C5)=O)NCCN)=O)([H])[C@H]4O

[1]Warn PA, et al. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus. Int J Antimicrob Agents. 2010 Feb;35 (2) :146-51.|[2]Ghannoum MA, et al. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. J Antimicrob Chemother. 2007 Mar;59 (3) :556-9.